
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $300.5M | -- | -- | -$0.65 | -- |
08/07/2025 | Q2 | $273.9M | -- | -- | -$0.84 | -- |
05/06/2025 | Q1 | $204.2M | $219.5M | -$1.70 | -$1.16 | -$0.54 |
02/19/2025 | Q4 | $189.2M | $170.7M | -$5.00 | -$1.66 | -$3.34 |
11/06/2024 | Q3 | $270.9M | $260.9M | -$21.13 | -$1.64 | -$19.49 |
08/07/2024 | Q2 | $262.4M | $265.4M | -$2.31 | -$1.56 | -$0.75 |
05/08/2024 | Q1 | $195.1M | $204.4M | -$2.75 | -$1.59 | -$1.16 |
02/20/2024 | Q4 | $325M | $316M | -$2.85 | -$1.34 | -$1.51 |
11/01/2023 | Q3 | -- | -- | -$1.08 | $0.74 | -$1.82 |
08/01/2023 | Q2 | -- | -- | $2.03 | $2.56 | -$0.53 |
05/03/2023 | Q1 | -- | -- | $2.35 | $1.95 | $0.40 |
02/13/2023 | Q4 | -- | -- | $0.36 | $1.59 | -$1.23 |
11/07/2022 | Q3 | -- | -- | $0.43 | $1.44 | -$1.01 |
08/02/2022 | Q2 | -- | -- | $0.26 | $1.40 | -$1.14 |
05/02/2022 | Q1 | -- | -- | $0.60 | $1.31 | -$0.71 |
02/15/2022 | Q4 | -- | -- | $0.74 | $1.32 | -$0.58 |
11/02/2021 | Q3 | -- | -- | $0.96 | $1.38 | -$0.42 |
08/02/2021 | Q2 | -- | -- | $0.82 | $1.11 | -$0.29 |
05/03/2021 | Q1 | -- | -- | $0.55 | $1.01 | -$0.46 |
02/16/2021 | Q4 | -- | -- | $0.33 | $0.88 | -$0.55 |
11/02/2020 | Q3 | -- | -- | $0.83 | $0.85 | -$0.02 |
08/03/2020 | Q2 | -- | -- | $0.70 | $0.71 | -$0.01 |
05/06/2020 | Q1 | -- | -- | $0.81 | $1.27 | -$0.46 |
02/19/2020 | Q4 | -- | -- | $1.03 | $1.25 | -$0.22 |
11/06/2019 | Q3 | -- | -- | $0.81 | $1.13 | -$0.32 |
08/06/2019 | Q2 | -- | -- | $0.94 | $0.83 | $0.11 |
05/06/2019 | Q1 | -- | -- | $0.64 | $0.57 | $0.07 |
02/20/2019 | Q4 | -- | -- | $0.63 | $0.69 | -$0.06 |
11/01/2018 | Q3 | -- | -- | $0.86 | $0.82 | $0.04 |
08/02/2018 | Q2 | -- | -- | $0.82 | $0.84 | -$0.02 |
05/09/2018 | Q1 | -- | -- | $0.87 | $0.80 | $0.07 |
02/14/2018 | Q4 | -- | -- | $0.85 | $0.66 | $0.20 |
11/08/2017 | Q3 | -- | -- | $0.66 | $0.55 | $0.11 |
08/02/2017 | Q2 | -- | -- | $0.55 | $0.37 | $0.18 |
05/09/2017 | Q1 | -- | -- | $0.36 | $0.30 | $0.06 |
08/09/2016 | Q2 | -- | -- | $0.44 | $0.41 | $0.03 |
SolarEdge Technologies reported $219.5M worth of top line sales in its most recent quarter.
SolarEdge Technologies announced earnings per share of -$1.70 which represents a miss of analyst forecast a -$1.16 per share.
SolarEdge Technologies reported $17.5M that represents $0.30 per share over the last quarter.
SolarEdge Technologies's earnings are forecast to decrease from -$31.64 per share to -$19.28 per share next year representing a decrease of -89.74%.
SolarEdge Technologies's next earnings date is August 7, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.